EMEA Sterility Testing Market Research Report –Regional Forecast till 2023

EMEA Sterility Testing Market Research Report –Regional Forecast till 2023

ID: MRFR/LS/0153-HCRR | February, 2018 | Region: Global | 90 pages | Half-Cooked Research Reports

EMEA Sterility Testing Market Research Report: by Product (Reagents, Services), by Test (Membrane Filtration, Direct Inoculation), by Application (Pharmaceutical, Biotechnology Industries), by End Users (Hospitals & Clinics) – EMEA forecast till 2023 


Market Scenario: 


Sterilisation is any process that effectively eradicates any surface, equipment or article from the presence of viable microorganisms. Sterility testing is one of the important aspects of the healthcare sector which ensures the purity and safety of a product or a substance. Increasing prevalence of chronic diseases like cancer and HIV which can be easily transferred from the patient to the healthy adults through the use of the contaminated articles is one of the major drivers for the market growth. In 2015, according to the Centers for Disease Control and Prevention, 9,250 out of every 10,000 exposures to infected blood transfusion resulted in the transmission of the HIV. Similar, results were estimated by the use of infected needle during the parenteral intake of the drugs, 63 out of every 10,000 such exposures led to HIV. Moreover, expanding pharmaceutical and biotech industries, the rise in the approval of the drugs, growth in R&D investments in life science research along with rising healthcare and government support is expected to boost the market growth during the forecast period. However, precise regulatory and time-consuming approval processes along with the lack of skilled labor will restrain the market growth during the forecast period. 

The EMEA sterility testing market is expected to grow at an approximate CAGR of 10.8% during the forecast period.

Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 


Figure 1:- EMEA sterility testing market share, by region

EMEA sterility testing market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Segmentation


The EMEA sterility testing market is segmented on the basis of product, test, application and end users.


On the basis of the product, the market is segmented into kits & reagents, services, instruments, and others.


On the basis of the test, the market is segmented into membrane filtration, direct inoculation sterility testing, and others. The membrane filtration segment is sub-segmented into membrane type which is further segmented into synthetic organic polymers and inorganic materials. The synthetic organic polymers, by membrane type, is sub-segmented into polysulfone, cellulose acetate, and others. The inorganic materials, by membrane type, is sub-segmented into ceramic membranes, metal membranes, others.


On the basis of the application, the market is segmented into pharmaceutical industries, biotechnology industries, and others.


On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, research organization, and others. 


Regional Analysis 


Europe is the largest sterility testing market. High healthcare expenditures, government support for research & development and huge patient population drives the European market. Moreover, growing biotechnology and pharmaceutical industries is boosting the market growth. Additionally, the presence of the developed economies within the region like the U.K and France is fuelling the market growth during the forecast period. Regionally Europe is divided into Western Europe and Eastern Europe. Western Europe leads the market within the region. On the other hand, there are huge opportunities for the market growth in Eastern Europe. 


Asia Pacific is the fastest growing region in EMEA market due to the presence of a huge patient population and continuously developing economies like India and China which have a growing healthcare industry. According to the Indian Brand Equity Foundation, in 2017, the Indian healthcare sector is one of the fastest growing industries and is expected to advance at a CAGR of 22.8% and reach USD 280 billion by 2020. Additionally, favorable government policies like reduced excise and customs duty followed by the exemptions in service tax in India boosts the regional market growth. 


The Middle East & Africa holds the least share in the EMEA sterility testing market due to the presence of poor economies in the African region owing to the low per capita income and stringent government policies within the region. A majority of the Middle East & Africa market is held by the Middle East due to huge healthcare expenditures and presence of developed economies like Kuwait, Saudi Arabia, Dubai, and Qatar.  


Research Methodology

Europe Sterility Testing Market


Sources: WHO, annual reports, press release, white paper, and company presentation


Key players for EMEA sterility testing market


Some of the major players in the market are Merck KGaA (Germany), bioMérieux SA (France), SGS SA (Switzerland), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Toxikon, Inc. (U.S.), Charles River (U.S.), and others.


 


 

TABLE OF CONTENT    

Chapter 1.    Report Prologue    

Chapter 2.    Market Introduction    


      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

Chapter 3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research    

      3.4    Market Size Estimation

Chapter 4.    Market Dynamics

      4.1    Drivers    

      4.2    Restrains

      4.3    Opportunities    

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Test Trends & Assessment            

Chapter 5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers    

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis    

      5.4    Pricing Analysis

Chapter 6.    EMEA Sterility Testing Market, by Product

     6.1    Introduction

      6.2    Kits & Reagents

Market Estimates & Forecast, 2017 – 2023

      6.3    Services

Market Estimates & Forecast, 2017 – 2023

    6.4    Instruments

      6.5    Others

Chapter 7.    EMEA Sterility Testing Market, by Test

     7.1    Introduction

      7.2    Membrane Filtration

Market Estimates & Forecast, 2017 – 2023

            7.2.1    Membrane Type

                7.2.1.1    Synthetic Organic Polymers

                  7.2.1.1.1    Polysulfone

                  7.2.1.1.2    Cellulose Acetate

                  7.2.1.1.3    Others

                7.2.1.2    Inorganic Materials

                  7.2.1.2.1    Ceramic Membranes

                  7.2.1.2.2    Metal Membranes

                  7.2.1.2.3    Others

            7.2.2    Direct Inoculation Sterility Testing

            7.2.3    Others

Chapter 8.    EMEA Sterility Testing Market, by Application

      8.1    Introduction

      8.2    Pharmaceutical Industries

Market Estimates & Forecast, 2017 – 2023

      8.3    Biotechnology Industries

Market Estimates & Forecast, 2017 – 2023

      8.4    Others

Chapter 9.    EMEA Sterility Testing Market, by End Users

      9.1    Introduction

      9.2    Hospitals & Clinics

Market Estimates & Forecast, 2017 – 2023

      9.3    Research Organization

Market Estimates & Forecast, 2017 – 2023

      9.4    Retail Pharmacies

Market Estimates & Forecast, 2017 – 2023

      9.5    Others

Chapter 10.    EMEA Sterility Testing Market, by Region

      10.1    Introduction

      10.2    America

            10.2.1    North America

                10.2.1.1    US

                10.2.1.2    Canada

            10.2.2    South America

      10.3    Europe

            10.3.1    Western Europe

                10.3.1.1    Germany

                10.3.1.2    France

                10.3.1.3    Italy

                10.3.1.4    Spain

                10.3.1.5    U.K

                10.3.1.6    Rest of Western Europe

            10.3.2    Eastern Europe

      10.4    Asia Pacific

            10.4.1    Japan

            10.4.2    China

            10.4.3    India

            10.4.4    Australia

            10.4.5    Republic of Korea

            10.4.6    Rest of Asia Pacific

      10.5    The Middle East & Africa

            10.5.1    United Arab Emirates

            10.5.2    Saudi Arabia

            10.5.3    Oman

            10.5.4    Kuwait

            10.5.5    Qatar

            10.5.6    Rest of the Middle East & Africa

Chapter 11.    Company Landscape    

      11.1    Introduction    

      11.2    Market Share Analysis    

      11.3    Key Development & Strategies    

            11.3.1    Key Developments    

Chapter 12    Company Profiles    

      12.1    Merck KGaA 

            12.1.1    Company Overview    

            12.1.2    Product Overview    

            12.1.3    Financials

            12.2.4    Key Developments    

            12.1.5    SWOT Analysis    

      12.2    bioMérieux SA 

            12.2.1    Company Overview    

            12.2.2    Product Overview    

            12.2.3    Financial Overview    

            12.2.4    Key Developments    

            12.2.5    SWOT Analysis    

      12.3    SGS SA 

            12.3.1    Company Overview    

            12.3.2    Product Overview    

            12.3.3    Financial Overview

            12.3.4    Key Development    

            12.3.5    SWOT Analysis    

      12.4    Sartorius AG 

            12.4.1    Company Overview    

            12.4.2    Product/Business Segment Overview    

            12.4.3    Financial Overview    

            12.4.4    Key Development    

            12.4.5    SWOT Analysis    

      12.5    Thermo Fisher Scientific Inc.  

            12.5.1    Company Overview    

            12.5.2    Product Overview    

            12.5.3    Financial overview    

            12.5.4    Key Developments    

            12.5.5    SWOT Analysis    

12.6    Toxikon, Inc.  

            12.6.1    Company Overview    

            12.6.2    Product Overview    

            12.6.3    Financial Overview    

            12.6.4    Key Developments    

            12.6.5    SWOT Analysis    

12.7    Charles River 

            12.7.1    Overview    

            12.7.2    Product Overview    

            12.7.3    Financials    

            12.7.4    Key Developments    

            12.7.5    SWOT Analysis        

      12.8    Others

Chapter 13    MRFR Conclusion    

      13.1    Key Findings    

            13.1.1    From CEO’s View Point    

            13.1.2    Unmet Needs of the Market    

      13.2    Key Companies to Watch    

      13.3    Prediction of Sterility Testing Market Market

Chapter 14    Appendix

LIST OF TABLES


Table 1        Sterility Testing Market Industry Synopsis, 2017 – 2023

Table 2        EMEA Sterility Testing Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3        EMEA Sterility Testing Market by Region, 2017 – 2023, (USD Million)

Table 4        EMEA Sterility Testing Market by Product, 2017 – 2023, (USD Million)

Table 5        EMEA Sterility Testing Market by Test, 2017 – 2023, (USD Million)

Table 6        EMEA Sterility Testing Market by Application, 2017 – 2023, (USD Million)

Table 7        EMEA Sterility Testing Market by End Users, 2017 – 2023, (USD Million)

Table 8        Europe Sterility Testing Market by Product, 2017 – 2023, (USD Million)

Table 9        Europe Sterility Testing Market by Test, 2017 – 2023, (USD Million)

Table 10    Europe Sterility Testing Market by Application, 2017 – 2023, (USD Million)

Table 11    Europe Sterility Testing Market by End Users, 2017 – 2023, (USD Million)

Table 12    Western Europe Sterility Testing Market by Product, 2017 – 2023, (USD Million)

Table 13    Western Europe Sterility Testing Market by Test, 2017 – 2023, (USD Million)

Table 14    Western Europe Sterility Testing Market by Application, 2017 – 2023, (USD Million)

Table 15    Western Europe Sterility Testing Market by End Users, 2017 – 2023, (USD Million)

Table 16    Eastern Europe Sterility Testing Market by Product, 2017 – 2023, (USD Million)

Table 17    Eastern Europe Sterility Testing Market by Test, 2017 – 2023, (USD Million)

Table 18    Eastern Europe Sterility Testing Market by Application, 2017 – 2023, (USD Million)

Table 19    Eastern Europe Sterility Testing Market by End Users, 2017 – 2023, (USD Million)

Table 20    Asia Pacific Sterility Testing Market by Product, 2017 – 2023, (USD Million)

Table 21    Asia Pacific Sterility Testing Market by Test, 2017 – 2023, (USD Million)

Table 22    Asia Pacific Sterility Testing Market by Application, 2017 – 2023, (USD Million)

Table 23    Asia Pacific Sterility Testing Market by End Users, 2017 – 2023, (USD Million)

Table 24    Middle East & Africa Sterility Testing Market by Product, 2017 – 2023, (USD Million)

Table 25    Middle East & Africa Sterility Testing Market by Test, 2017 – 2023, (USD Million)

Table 26    Middle East & Africa Sterility Testing Market by Application, 2017 – 2023, (USD Million)

Table 27    Middle East & Africa Sterility Testing Market by End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for EMEA Sterility Testing Market

Figure 3    Market Dynamics for EMEA Sterility Testing Market

Figure 4    EMEA Sterility Testing Market Share, by Product 2016

Figure 5    EMEA Sterility Testing Market Share, by Test 2016

Figure 6    EMEA Sterility Testing Market Share, by Application 2016

Figure 7    EMEA Sterility Testing Market Share, by End Users, 2016

Figure 8    EMEA Sterility Testing Market Share, by Region, 2016

Figure 9    Europe Sterility Testing Market Share, by Country, 2016

Figure 10    Asia Pacific Sterility Testing Market Share, by Country, 2016

Figure 11    Middle East & Africa Sterility Testing Market Share, by Country, 2016

Figure 12    EMEA Sterility Testing Market: Company Share Analysis, 2016 (%)

Figure 13    Merck KGaA: Key Financials

Figure 14    Merck KGaA: Segmental Revenue

Figure 15    Merck KGaA: Geographical Revenue

Figure 16    bioMérieux SA:  Product UK Ltd: Key Financials

Figure 17    bioMérieux SA: Product UK Ltd: Segmental Revenue

Figure 18    bioMérieux SA:  Product UK Ltd: Geographical Revenue

Figure 19    SGS SA: Key Financials

Figure 20    SGS SA: Segmental Revenue

Figure 21    SGS SA: Geographical Revenue

Figure 22    Sartorius AG: Key Financials

Figure 23    Sartorius AG: Segmental Revenue

Figure 24    Sartorius AG: Geographical Revenue

Figure 25    Thermo Fisher Scientific Inc.: Key Financials

Figure 26    Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 27    Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 28    Toxikon, Inc.: Key Financials

Figure 29    Toxikon, Inc.: Segmental Revenue

Figure 30    Toxikon, Inc.: Geographical Revenue

Figure 31    Charles River:  Key Financials

Figure 32    Charles River: Segmental Revenue

Figure 33    Charles River: Geographical Revenue